2nd Quarter - Report

FORBES-TATE for PHRMA

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues pertaining to Rx drug pricing.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Issues related to Direct to Consumer (DTC) Advertising.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues pertaining to Rx drug pricing.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues pertaining to Rx drug pricing; Issues related to IPAB; Medicare Part D related issues; Issues regarding the importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (Public Law 98-417); Issues regarding H.R.965/S. 340 - CREATES Act of 2019; Issues regarding H.R. 985 - FAST Generics Act of 2019.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 965 (116th), S. 340 (116th), H.R. 985 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.